Philippe Sauvage
Chief Financial Officer · Nuvation Bio Inc.
- 2024
- Jul 17, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Philippe Sauvage files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gary Hattersley - $3.88M in NUVB purchases and sales in the last 12 months
- Dongfang Liu - $1.87M in NUVB purchases and sales in the last 12 months
- Kerry Wentworth - $1.47M in NUVB purchases and sales in the last 12 months
- David C. Hanley - $1.43M in NUVB purchases and sales in the last 12 months
- Stacy Markel - $753K in NUVB purchases and sales in the last 12 months
- Robert Mashal - $118K in NUVB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Philippe Sauvage?
Philippe Sauvage is a corporate insider, tracked as Chief Financial Officer of Nuvation Bio Inc. (NUVB). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Philippe Sauvage submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Philippe Sauvage been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($286K) across all tracked filings.